Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0819072B2 - (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same - Google Patents
[go: Go Back, main page]

JPH0819072B2 - (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same - Google Patents

(2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same

Info

Publication number
JPH0819072B2
JPH0819072B2 JP63165910A JP16591088A JPH0819072B2 JP H0819072 B2 JPH0819072 B2 JP H0819072B2 JP 63165910 A JP63165910 A JP 63165910A JP 16591088 A JP16591088 A JP 16591088A JP H0819072 B2 JPH0819072 B2 JP H0819072B2
Authority
JP
Japan
Prior art keywords
group
amino
mmol
mixture
phenylbutyronitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63165910A
Other languages
Japanese (ja)
Other versions
JPH0217165A (en
Inventor
孜郎 寺島
冬彦 松田
光代 松本
正子 大崎
芳雄 伊藤
邦和 酒井
大英 常本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sagami Chemical Research Institute
Original Assignee
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chemical Research Institute filed Critical Sagami Chemical Research Institute
Priority to JP63165910A priority Critical patent/JPH0819072B2/en
Publication of JPH0217165A publication Critical patent/JPH0217165A/en
Publication of JPH0819072B2 publication Critical patent/JPH0819072B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は一般式 (式中、R1は炭素数1〜4の直鎖もしくは分枝アルカノ
イル基、塩素原子もしくはメトキシ基で置換されていて
もよいアロイル基、炭素数1〜5の直鎖もしくは分枝ア
ルコキシカルボニル基、または塩素原子もしくはメトキ
シ基で置換されていてもよいアラルコキシカルボニル基
を表し、R2は水素原子、炭素数1〜4の直鎖もしくは分
枝アルキル基、または塩素原子もしくはメトキシ基で置
換されていてもよいアリール基を表す。)で表される
(2S,3R)−3−アミノ−2−アシルオキシ−4−フェ
ニルブチロニトリル誘導体およびその製造方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] (In the formula, R 1 is a linear or branched alkanoyl group having 1 to 4 carbon atoms, an aroyl group optionally substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms. Or a aralkoxycarbonyl group which may be substituted with a chlorine atom or a methoxy group, and R 2 is substituted with a hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms, or a chlorine atom or a methoxy group. (2S, 3R) -3-amino-2-acyloxy-4-phenylbutyronitrile derivative represented by the formula (1), which represents an optionally substituted aryl group, and a method for producing the same.

本発明の一般式(I)で表される(2S,3R)−3−ア
ミノ−2−アシルオキシ−4−フェニルブチロニトリル
誘導体は、免疫賦活作用により制癌剤として有用なベス
タチンの製造中間体である光学活性(2S,3R)−3−ア
ミノ−2−ヒドロキシ−4−フェニル酪酸の合成原料と
して使用できる(J.Antibiot.,29,600(1976).,J.Anti
biot.,36,695(1983).,J.Med.Chem.,20,510(1977).,
Tetrahedron Lett.,25,5079(1984).,および参考例参
照)。
The (2S, 3R) -3-amino-2-acyloxy-4-phenylbutyronitrile derivative represented by the general formula (I) of the present invention is an intermediate for producing bestatin useful as a carcinostatic agent due to its immunostimulating action. It can be used as a raw material for the synthesis of optically active (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid (J. Antibiot., 29 , 600 (1976)., J. Anti.
biot., 36 , 695 (1983)., J. Med. Chem., 20 , 510 (1977).,
Tetrahedron Lett., 25 , 5079 (1984)., And reference examples).

〔従来の技術〕[Conventional technology]

ベスタチンの製造中間体である光学活性(2S,3R)−
3−アミノ−2−ヒドロキシ−4−フェニル酪酸は、従
来、1)D−フェニルアラニンから合成した(R)−2
−ベンジルオキシカルボニルアミノ−3−フェニルプロ
パナールの酸性亜硫酸ナトリウム付加物からシアノヒド
リン誘導体を合成し、これを加水分解する方法(J.Anti
biot.,29,600(1976).,およびJ.Med.Chem.,20,510(19
77).)2)N−ベンゾイルフェナシルアミンとグリコ
ール酸とのアルドール付加反応を鍵工程として合成した
dl−体の(2S*,3R*)−3−ベンゾイルアミノ−2−ヒ
ドロキシ−4−フェニル酪酸を光学分割する方法(J.An
tibiot.,36,695(1983).)3)D−フェニルアラニン
から合成した(S)−N−ベンジル−N−ベンジルオキ
シカルボニル−1−ベンジルアリルアミンのハロシクロ
カルバモイル化反応を応用した方法(Tetrahedron Let
t.,25,5079(1984).)によって合成されている。1)
の方法は、2位に関して反応の立体選択性が大変低く、
所望の(S)−配置を有する化合物と不要の(R)−配
置を有する化合物の混合物を与え、その分離には多大の
困難をともなっていた。2)の方法では効率の低い化学
分割が行われており、所望の(2S,3R)−3−アミノ−
2−ヒドロキシ−4−フェニル酪酸の収率は大変低いも
のであった。また、3)の方法は多段階であるうえに、
液体アンモニア中金属ナトリウムを用いてN−ベンジル
基を除去するなど、工業的に到底実施しえない工程が用
いられている。
Optically active (2S, 3R) -an intermediate for the production of bestatin
3-Amino-2-hydroxy-4-phenylbutyric acid has conventionally been synthesized from 1) D-phenylalanine (R) -2.
-A method for synthesizing a cyanohydrin derivative from an acidic sodium sulfite adduct of benzyloxycarbonylamino-3-phenylpropanal and hydrolyzing it (J. Antiti
biot., 29, 600 (1976 )., and J.Med.Chem., 20, 510 (19
77). 2) 2) Aldol addition reaction of N-benzoylphenacylamine and glycolic acid was synthesized as a key step.
Method for optical resolution of dl-form (2S * , 3R * )-3-benzoylamino-2-hydroxy-4-phenylbutyric acid (J. An
tibiot., 36 , 695 (1983). 3) A method applying the halocyclocarbamoylation reaction of (S) -N-benzyl-N-benzyloxycarbonyl-1-benzylallylamine synthesized from D-phenylalanine (Tetrahedron Let
t., 25 , 5079 (1984). ) Is synthesized by. 1)
The method has a very low stereoselectivity of the reaction at the 2-position,
This gave a mixture of compounds with the desired (S) -configuration and unwanted compounds with the (R) -configuration, the separation of which was very difficult. In the method 2), low-efficiency chemical resolution is performed, and the desired (2S, 3R) -3-amino-
The yield of 2-hydroxy-4-phenylbutyric acid was very low. In addition, the method of 3) has multiple stages, and
Industrially impossible steps such as removal of N-benzyl group using sodium metal in liquid ammonia are used.

〔発明が解決しようとする問題点〕[Problems to be solved by the invention]

本発明者らは、ベスタチンの製造中間体である光学活
性(2S,3R)−3−アミノ−2−ヒドロキシ酪酸誘導体
を高立体選択的に製造する方法を探索した結果、本発明
の化合物およびその製造方法を見出し、本発明を完成し
た。
The present inventors searched for a method for highly stereoselectively producing an optically active (2S, 3R) -3-amino-2-hydroxybutyric acid derivative, which is an intermediate for the production of bestatin, and as a result, the compound of the present invention and its The manufacturing method was found and the present invention was completed.

〔問題点を解決するための手段〕[Means for solving problems]

前記一般式(I)で表される新規な(2S,3R)−3−
アミノ−2−アシルオキシ−4−フェニルブチロニトリ
ル誘導体は下記の反応式に従い製造できる。
The novel (2S, 3R) -3- represented by the general formula (I)
The amino-2-acyloxy-4-phenylbutyronitrile derivative can be produced according to the following reaction formula.

(式中、R1、R2は前記と同じ意味を表し、R4は炭素数1
〜4の直鎖または分枝低級アルキル基を表す。) (第1工程) 本工程は一般式(II)で表されるD−フェニルアラニ
ンエステル塩酸塩にアミノ基の保護基を導入後エステル
基を還元し、一般式(III)で表される(R)−2−ア
ミノプロパノール誘導体を製造するものである(参考例
参照)。
(In the formula, R 1 and R 2 have the same meanings as described above, and R 4 has 1 carbon atom.
4 represents a straight chain or branched lower alkyl group. (Step 1) In this step, a protective group for an amino group is introduced into D-phenylalanine ester hydrochloride represented by the general formula (II), and then the ester group is reduced to obtain the compound represented by the general formula (III) (R ) -2-Aminopropanol derivative is produced (see Reference Example).

D−フェニルアラニンエステル塩酸塩としては、D−
フェニルアラニンメチルエステル塩酸塩、D−フェニル
アラニンエチルエステル塩酸塩、D−フェニルアラニン
イソプロピルエステル塩酸塩などが例示でき、これらの
ものは公知の方法によって製造できる(Chem.Pharm.Bul
l.,13,995(1965).,およびS.R.Sandler and W.Karo,
“Functional Group Preparations",Academic Press,Ne
w York,1968,pp245-265.参照)。
Examples of D-phenylalanine ester hydrochloride include D-
Examples thereof include phenylalanine methyl ester hydrochloride, D-phenylalanine ethyl ester hydrochloride, D-phenylalanine isopropyl ester hydrochloride and the like, which can be produced by a known method (Chem.Pharm.Bul.
l., 13 , 995 (1965)., and SR Sandler and W. Karo,
"Functional Group Preparations", Academic Press, Ne
w York, 1968, pp 245-265.).

D−フェニルアラニンエステル塩酸塩に導入されるア
ミノ基の保護基である置換基R1としては、ホルミル基、
アセチル基、プロピオニル基、ブチリル基、イソブチリ
ル基などの炭素数1〜4の直鎖もしくは分枝アルカノイ
ル基、ベンゾイル基、p−クロロベンゾイル基、p−メ
トキシベンゾイル基などの塩素原子もしくはメトキシ基
で置換されていてもよいアロイル基、メトキシカルボニ
ル基、エトキシカルボニル基、イソプロポキシカルボニ
ル基、t−ブチルオキシカルボニル基などの炭素数1〜
5の直鎖あるいは分枝アルコキシカルボニル基、ベンジ
ルオキシカルボニル基、p−クロロベンジルオキシカル
ボニル基、p−メトキシベンジルオキシカルボニル基な
どの無置換あるいは置換アラルコキシカルボニル基が用
いられる。これらの保護基は公知の方法によって導入で
きる(T.W.Greene,“Protective Groups in Organic Sy
nthesis",John-Wiley&Sons,New York,1980,pp218-287.
参照)。
As the substituent R 1 which is a protective group for the amino group introduced into D-phenylalanine ester hydrochloride, a formyl group,
Substituted with a chlorine atom such as an acetyl group, a propionyl group, a butyryl group, an isobutyryl group or a branched alkanoyl group having 1 to 4 carbon atoms, a benzoyl group, a p-chlorobenzoyl group, a p-methoxybenzoyl group or a methoxy group Aroyl group, methoxycarbonyl group, ethoxycarbonyl group, isopropoxycarbonyl group, t-butyloxycarbonyl group and the like having 1 to 1 carbon atoms
An unsubstituted or substituted aralkoxycarbonyl group such as a straight chain or branched alkoxycarbonyl group of 5, a benzyloxycarbonyl group, a p-chlorobenzyloxycarbonyl group and a p-methoxybenzyloxycarbonyl group is used. These protecting groups can be introduced by a known method (TW Greene, “Protective Groups in Organic Sy
nthesis ", John-Wiley & Sons, New York, 1980, pp218-287.
reference).

アミノ基が保護されたD−フェニルアラニンエステル
のエステル基の還元は、適当な還元剤、例えば、塩化リ
チウムまたは臭化リチウム存在下、水素化ホウ素ナトリ
ウムを用いて行われる(参考例参照)。
The reduction of the ester group of the amino-protected D-phenylalanine ester is carried out using sodium borohydride in the presence of a suitable reducing agent such as lithium chloride or lithium bromide (see Reference Example).

本工程においては、一般式(III)で表される(R)
−2−アミノ−3−フェニルプロパノール誘導体がラセ
ミ化することなく得られる。
In this step, (R) represented by the general formula (III)
The 2-amino-3-phenylpropanol derivative is obtained without racemization.

(第2工程) 本工程は一般式(III)で表される(R)−2−アミ
ノ−3−フェニルプロパノール誘導体を酸化し、一般式
(IV)で表される(R)−2−アミノ−3−フェニルプ
ロパナール誘導体を製造するものである。好適な酸化方
法としては、ジメチルスルホキシド中三酸化イオウ−ピ
リジン錯体−トリエチルアミンを用いる方法が例示でき
る(Chem,Pharm.Bull.,30,1921(1982).,および参考例
参照)。本工程もラセミ化することなく進行する。
(Second Step) In this step, the (R) -2-amino-3-phenylpropanol derivative represented by the general formula (III) is oxidized to give the (R) -2-amino represented by the general formula (IV). A method for producing a 3-phenylpropanal derivative. An example of a suitable oxidation method is a method using sulfur trioxide in dimethyl sulfoxide-pyridine complex-triethylamine (see Chem, Pharm. Bull., 30 , 1921 (1982)., And Reference Example). This step also proceeds without racemization.

(第3工程) 本工程は一般式(IV)で表される(R)−2−アミノ
−3−フェニルプロパナール誘導体を、一般式 R2COOCOR3 −(V) (式中、R2、R3は各々独立に、水素原子、炭素数1〜4
の直鎖もしくは分枝アルキル基、または塩素原子もしく
はメトキシ基で置換されていてもよいアリール基を表
す。)で表されるカルボン酸無水物および青酸塩と、第
4級アンモニウム塩もしくは第3級アミンまたは第4級
アンモニウム塩および第3級アミンの存在下反応させる
ことにより、本発明の化合物である一般式(I)で表さ
れる(2S,3R)−3−アミノ−2−アシルオキシ−4−
フェニルブチロニトリル誘導体を製造するものである。
(Third Step) In this step, the (R) -2-amino-3-phenylpropanal derivative represented by the general formula (IV) is converted to the general formula R 2 COOCOR 3- (V) (wherein R 2 , R 3's each independently represent a hydrogen atom or a carbon number of 1 to 4.
Represents a linear or branched alkyl group, or an aryl group which may be substituted with a chlorine atom or a methoxy group. ), A carboxylic acid anhydride and a hydrocyanic acid salt are reacted with a quaternary ammonium salt or a tertiary amine or a quaternary ammonium salt and a tertiary amine to give a compound of the present invention. (2S, 3R) -3-Amino-2-acyloxy-4-represented by formula (I)
A phenylbutyronitrile derivative is produced.

一般式(V)で表されるカルボン酸無水物としては、
ギ酸酪酸無水物、無水酢酸、無水プロピオン酸、無水イ
ソ酪酸、無水安息香酸、無水p−クロロ安息香酸、無水
p−メトキシ安息香酸などが例示できるが、好適には無
水酢酸あるいは無水安息香酸が用いられる。用いられる
カルボン酸無水物は(R)−2−アミノ−3−フェニル
プロパナール誘導体に対して1.0〜20当量用いられる
が、2.5〜7.0当量用いた場合に好ましい結果が得られ
る。第4級アンモニウム塩としては、塩化テトラブチル
アンモニウム、臭化テトラブチルアンモニウム、塩化ベ
ンジルトリメチルアンモニウム、臭化ベンジルトリメチ
ルアンモニウム、塩化ベンジルトリエチルアンモニウ
ム、塩化ベンジルトリブチルアンモニウム、臭化ベンジ
ルトリブチルアンモニウム、塩化メチルトリオクチルア
ンモニウム、塩化N−ベンジルキニジニウム、塩化N−
ベンジルキニニウム、塩化N−ベンジルシンコニジニウ
ム、塩化N−ベンジルシンコニニウム、塩化N−ベンジ
ル−N−メチルエフェドリニウムなどが例示される。第
4級アンモニウム塩は、(R)−2−アミノ−3−フェ
ニルプロパナール誘導体に対して0.005〜0.20当量用い
られるが0.01〜0.07当量用いた場合に好ましい結果が得
られる。
As the carboxylic acid anhydride represented by the general formula (V),
Formic acid butyric anhydride, acetic anhydride, propionic anhydride, isobutyric anhydride, benzoic anhydride, p-chlorobenzoic anhydride, p-methoxybenzoic anhydride and the like can be exemplified, but acetic anhydride or benzoic anhydride is preferably used. To be The carboxylic acid anhydride used is used in an amount of 1.0 to 20 equivalents relative to the (R) -2-amino-3-phenylpropanal derivative, and preferable results are obtained when used in 2.5 to 7.0 equivalents. Examples of the quaternary ammonium salt include tetrabutylammonium chloride, tetrabutylammonium bromide, benzyltrimethylammonium chloride, benzyltrimethylammonium bromide, benzyltriethylammonium chloride, benzyltributylammonium chloride, benzyltributylammonium bromide, and methyltrioctyl chloride. Ammonium, N-benzylquinidinium chloride, N-chloride
Examples thereof include benzylquininium, N-benzylcinchonidinium chloride, N-benzylcinchoninium chloride, and N-benzyl-N-methylephedrinium chloride. The quaternary ammonium salt is used in 0.005 to 0.20 equivalent with respect to the (R) -2-amino-3-phenylpropanal derivative, but when 0.01 to 0.07 equivalent is used, preferable results are obtained.

第3級アミンとしては、トリメチルアミン、トリエチ
ルアミン、エチルジイソプロピルアミン、トリブチルア
ミン、N,N−テトラメチルエチレンジアミン、N−メチ
ルピロリジン、N−エチルピロリジン、N−ベンジルピ
ロリジン、N−メチルモルホリン、N−エチルモルホリ
ン、N−ベンジルモルホリン、1,4−ジアザビシクロ
〔2,2,2〕オクタン、1,5−ジアザビシクロ〔4,3,0〕ノ
ン−5−エン、1,8−ジアザビシクロ〔5,4,0〕ウンデク
−7−エン、ピリジン、2−メチルピリジン、2,4,5−
トリメチルピリジン、4−ジメチルアミノピリジン、キ
ノリンなどが例示できるが、好適には、ピリジン、4−
ジメチルアミノピリジンが用いられる。第3級アミンは
(R)−2−アミノ−3−フェニルプロパナール誘導体
に対して0.001〜0.10当量用いられるが、好適には0.005
〜0.02当量用いられる。
Examples of the tertiary amine include trimethylamine, triethylamine, ethyldiisopropylamine, tributylamine, N, N-tetramethylethylenediamine, N-methylpyrrolidine, N-ethylpyrrolidine, N-benzylpyrrolidine, N-methylmorpholine and N-ethylmorpholine. , N-benzylmorpholine, 1,4-diazabicyclo [2,2,2] octane, 1,5-diazabicyclo [4,3,0] non-5-ene, 1,8-diazabicyclo [5,4,0] Undec-7-ene, pyridine, 2-methylpyridine, 2,4,5-
Trimethylpyridine, 4-dimethylaminopyridine, quinoline and the like can be exemplified, but preferably, pyridine and 4-
Dimethylaminopyridine is used. The tertiary amine is used in 0.001 to 0.10 equivalent with respect to the (R) -2-amino-3-phenylpropanal derivative, and preferably 0.005.
~ 0.02 equivalents are used.

本反応に用いられる青酸塩としてはシアン化ナトリウ
ム、シアン化カリウムなどのアルカリ金属青酸塩が例示
できる。青酸塩は(R)−2−アミノ−3−フェニルプ
ロパナール誘導体に対して1.0〜10当量用いられるが、
1.5〜6.0当量用いた場合に好ましい結果が得られる。
Examples of the cyanide salt used in this reaction include alkali metal cyanide salts such as sodium cyanide and potassium cyanide. The cyanate salt is used in an amount of 1.0 to 10 equivalents relative to the (R) -2-amino-3-phenylpropanal derivative,
Preferred results are obtained when 1.5 to 6.0 equivalents are used.

本反応は有機溶媒中で行われ、より好ましくは水と有
機溶媒の二層系で行われる。用いられる有機溶媒として
は、ジクロロメタン、クロロホルム、四塩化炭素、1,2
−ジクロロエタン、1,1,1−トリクロロエタンなどのハ
ロゲン化炭化水素系溶媒、酢酸エチル、酢酸イソアミル
などの酢酸エステル類、トルエン、キシレンなどの炭化
水素系溶媒など水と混合しないものが例示できるが、好
適にはジクロロメタン、クロロホルム、1,2−ジクロロ
エタンが用いられる。水と有機溶媒との二層系で反応を
行う場合、その組成比は特に限定されないが、1:1の組
成比の場合に最も好ましい結果を与える。
This reaction is carried out in an organic solvent, more preferably a two-layer system of water and an organic solvent. The organic solvent used is dichloromethane, chloroform, carbon tetrachloride, 1,2
-Dichloroethane, halogenated hydrocarbon solvents such as 1,1,1-trichloroethane, ethyl acetate, acetic acid esters such as isoamyl acetate, toluene, hydrocarbon solvents such as xylene, which are immiscible with water, can be exemplified. Dichloromethane, chloroform and 1,2-dichloroethane are preferably used. When the reaction is carried out in a two-layer system of water and an organic solvent, the composition ratio is not particularly limited, but a composition ratio of 1: 1 gives the most preferable result.

本反応は−10〜50℃で行われるが、水と有機溶媒との
二層系で反応を行う場合、0〜5℃で最も好ましい結果
が得られる。
This reaction is carried out at -10 to 50 ° C, but when the reaction is carried out in a two-layer system of water and an organic solvent, the most preferable result is obtained at 0 to 5 ° C.

本反応によれば、一般式(I)で示される(2S,3R)
−配置を有する3−アミノ−2−アシルオキシ−4−フ
ェニルブチロニトリル誘導体が(2R,3R)−配置を有す
る3−アミノ−2−アシルオキシ−4−フェニルブチロ
ニトリル誘導体に対して高選択的(最大11:1)に生成す
ることができる。
According to this reaction, it is represented by the general formula (I) (2S, 3R)
3-Amino-2-acyloxy-4-phenylbutyronitrile derivatives having a -configuration are highly selective for 3-amino-2-acyloxy-4-phenylbutyronitrile derivatives having a (2R, 3R) -configuration Can be generated (up to 11: 1).

本反応をカルボン酸無水物の存在しない状態で行った
場合には、(R)−2−アミノ−3−フェニルプロパナ
ール誘導体から(2S,3R)−および(2R,3R)−3−アミ
ノ−2−ヒドロキシ−4−フェニルブチロニトリル誘導
体の等量混合物が得られる(比較例1および2参照)。
When this reaction is carried out in the absence of carboxylic acid anhydride, it is possible to obtain (2S, 3R)-and (2R, 3R) -3-amino- from (R) -2-amino-3-phenylpropanal derivative. An equal mixture of 2-hydroxy-4-phenylbutyronitrile derivative is obtained (see Comparative Examples 1 and 2).

上記の合成工程によって得られた一般式(I)で表さ
れる(2S,3R)−3−アミノ−2−アシルオキシ−4−
フェニルブチロニトリル誘導体を、酸性条件下加水分解
反応に付することによりニトリル基の加水分解と同時に
3位アミノ基と2位水酸基の脱保護を行うと、免疫賦活
作用により制癌剤として用いられるベスタチンの製造中
間体として用いられる式 で表される光学活性(2S,3R)−3−アミノ−2−ヒド
ロキシ−4−フェニル酪酸塩酸塩が収率よく得られる。
(2S, 3R) -3-Amino-2-acyloxy-4-, represented by the general formula (I), obtained by the above-mentioned synthesis step
When phenylbutyronitrile derivative is hydrolyzed under acidic conditions to hydrolyze the nitrile group and simultaneously deprotect the 3-position amino group and 2-position hydroxyl group, the immunosuppressive effect of bestatin used as a carcinostatic agent Formula used as a manufacturing intermediate The optically active (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid hydrochloride represented by is obtained in good yield.

以下、本発明の内容を実施例、参考例、比較例を用い
て詳細に説明するが、本発明はこれらによって何ら限定
されるものではない。
Hereinafter, the content of the present invention will be described in detail with reference to Examples, Reference Examples and Comparative Examples, but the present invention is not limited to these.

参考例1 (R)−フェニルアラニンメチルエステル塩酸塩3.9g
(18mmol)を無水テトラヒドロフラン20mlに懸濁し、氷
冷下、トリエチルアミン5.5ml(39mmol)、クロロ炭酸
イソプロピル2.3ml(20mmol)を加えて同温度で1時間
攪拌した。反応液を減圧下濃縮し、残渣に酢酸エチルを
加え、1M塩酸、飽和食塩水、飽和重曹水および飽和食塩
水で順次洗浄した。無水硫酸マグネシウム上で乾燥後、
減圧下に濃縮し、白色固体のN−(イソプロポキシカル
ボニル)−(R)−フェニルアラニンメチルエステル4.
7g(98%)を得た。
Reference example 1 (R) -Phenylalanine methyl ester hydrochloride 3.9g
(18 mmol) was suspended in 20 ml of anhydrous tetrahydrofuran, 5.5 ml (39 mmol) of triethylamine and 2.3 ml (20 mmol) of isopropyl chlorocarbonate were added under ice cooling, and the mixture was stirred at the same temperature for 1 hour. The reaction mixture was concentrated under reduced pressure, ethyl acetate was added to the residue, and the mixture was washed successively with 1M hydrochloric acid, saturated brine, saturated aqueous sodium hydrogen carbonate and saturated brine. After drying over anhydrous magnesium sulfate,
Concentrate under reduced pressure to give N- (isopropoxycarbonyl)-(R) -phenylalanine methyl ester as a white solid 4.
7 g (98%) were obtained.

Rf:0.76(クロロホルム/メタノール=30/1) IR(neat):1735,1680cm-1. NMR(CDCl3):δ1.21(6H,d,J=6Hz),3.11(2H,d,J=
6Hz),3.72(3H,s),4.50〜5.20(2H,m),4.92(1H,qui
ntet,J=6Hz),7.04〜7.48(5H,m). 参考例2 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニンメチルエステル4.7g(18mmol)を無水テトラ
ヒドロフラン23mlに溶解し、塩化リチウム2.3g(54mmo
l)、水素化ホウ素ナトリウム(53mmol)、無水エタノ
ール45mlを順次加え、室温で3時間攪拌した。反応液を
減圧下濃縮し、1M塩酸を加え(pH2〜3)析出結晶を濾
取した。水洗後、五酸化リン上で減圧乾燥し、N−(イ
ソプロポキシカルボニル)−(R)−フェニルアラニノ
ール3.6g(86%)を白色固体として得た。
Rf: 0.76 (chloroform / methanol = 30/1) IR (neat): 1735, 1680 cm -1 . NMR (CDCl 3 ): δ1.21 (6H, d, J = 6Hz), 3.11 (2H, d, J =
6Hz), 3.72 (3H, s), 4.50-5.20 (2H, m), 4.92 (1H, qui)
ntet, J = 6Hz), 7.04 to 7.48 (5H, m). Reference example 2 4.7 g (18 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalanine methyl ester was dissolved in 23 ml of anhydrous tetrahydrofuran, and 2.3 g of lithium chloride (54 mmo)
l), sodium borohydride (53 mmol), and 45 ml of absolute ethanol were sequentially added, and the mixture was stirred at room temperature for 3 hours. The reaction solution was concentrated under reduced pressure, 1M hydrochloric acid was added (pH 2-3), and the precipitated crystals were collected by filtration. After washing with water, it was dried under reduced pressure over phosphorus pentoxide to obtain 3.6 g (86%) of N- (isopropoxycarbonyl)-(R) -phenylalaninol as a white solid.

Rf:0.72(クロロホルム/メタノール=5/1) IR(KBr):1680cm-1. NMR(CDCl3):δ1.21(6H,d,J=6Hz),1.96〜2.30(1
H,m),2.88(2H,d,J=7Hz),3.44〜4.16(3H,m),4.65
〜5.13(1H,m),4.92(1H,quintet,J=6Hz),7.05〜7.4
7(5H,m). 参考例3 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール150mg(0.63mmol)、トルエン0.40ml、
ジメチルスルホキシド0.80ml(11mmol)、およびトリエ
チルアミン0.46ml(3.3mmol)の混合物に三酸化イオウ
−ピリジン錯塩510mg(3.2mmol)を加え、室温で30分間
攪拌した。反応液に氷水を加え、トルエンで抽出し、抽
出液を水、飽和重曹水、飽和食塩水で順次洗浄した。無
水硫酸ナトリウム上で乾燥後、減圧下に濃縮し、白色結
晶のN−(イソプロポキシカルボニル)−(R)−フェ
ニルアラニナール126mg(85%)を得た。このものは精
製することなく次の3−アミノ−2−アシルオキシブチ
ロニトリル誘導体の製造に供した。
Rf: 0.72 (chloroform / methanol = 5/1) IR (KBr): 1680 cm -1 . NMR (CDCl 3 ): δ1.21 (6H, d, J = 6Hz), 1.96 to 2.30 (1
H, m), 2.88 (2H, d, J = 7Hz), 3.44 to 4.16 (3H, m), 4.65
~ 5.13 (1H, m), 4.92 (1H, quintet, J = 6Hz), 7.05 ~ 7.4
7 (5H, m). Reference example 3 N- (isopropoxycarbonyl)-(R) -phenylalaninol 150 mg (0.63 mmol), toluene 0.40 ml,
510 mg (3.2 mmol) of sulfur trioxide-pyridine complex salt was added to a mixture of dimethyl sulfoxide 0.80 ml (11 mmol) and triethylamine 0.46 ml (3.3 mmol), and the mixture was stirred at room temperature for 30 minutes. Ice water was added to the reaction solution, and the mixture was extracted with toluene, and the extract was washed with water, saturated aqueous sodium hydrogen carbonate and saturated brine in that order. The extract was dried over anhydrous sodium sulfate and then concentrated under reduced pressure to obtain 126 mg (85%) of N- (isopropoxycarbonyl)-(R) -phenylalaninal as white crystals. This product was used for the next production of the 3-amino-2-acyloxybutyronitrile derivative without purification.

Rf:0.40(ヘキサン/酢酸エチル=7/3) 実施例1 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール30.0mg(0.13mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル25.0mg(0.11mmol)を塩化メチレン0.3mlに溶解し、
無水酢酸0.06ml(0.64mmol)、塩化ベンジルトリブチル
アンモニウム2.1mg(0.007mmol)、0.25Nシアン化ナト
リウム水溶液2.6ml(0.64mmol)を氷冷下順次加え、同
温度で3時間攪拌した。反応液に50%飽和食塩水を加
え、塩化メチレンで抽出し、抽出液を水、飽和食塩水で
順次洗浄した。無水硫酸ナトリウム上で乾燥後、減圧下
に濃縮し、残渣を薄層クロマトグラフィー(シリカゲ
ル、ヘキサン−酢酸エチル7:3)で精製し、無色オイル
状の(2S,3R)−2−アセトキシ−3−イソプロポキシ
カルボニルアミノ−4−フェニルブチロニトリルとその
(2R,3R)−体との混合物11.5mg(30%:N−(イソプロ
ポキシカルボニル)−(R)−フェニルアラニノールか
らの通算収率)を得た。(2S,3R)−体と(2R,3R)−体
との生成比はNMRスペクトル(400MHz)から10:1と決定
した。
Rf: 0.40 (hexane / ethyl acetate = 7/3) Example 1 25.0 mg (0.11 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 30.0 mg (0.13 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.3 ml of methylene chloride. Dissolves in
Acetic anhydride 0.06 ml (0.64 mmol), benzyltributylammonium chloride 2.1 mg (0.007 mmol), and 0.25N sodium cyanide aqueous solution 2.6 ml (0.64 mmol) were sequentially added under ice cooling, and the mixture was stirred at the same temperature for 3 hours. 50% Saturated saline was added to the reaction solution, extraction was performed with methylene chloride, and the extract was washed with water and saturated saline in this order. After drying over anhydrous sodium sulfate, the mixture was concentrated under reduced pressure and the residue was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 7: 3) to give colorless oily (2S, 3R) -2-acetoxy-3. 11.5 mg (30%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) of a mixture of -isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form ) Got. The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was determined to be 10: 1 from the NMR spectrum (400 MHz).

Rf:0.40(ヘキサン/酢酸エチル=7/3) IR(neat):1760,1700cm-1. NMR(CDCl3): (2R,3R)−体;δ1.16,1.22(6H,two d,J=each 6.0H
z),2.16(3H,s),2.89(1H,dd,J=14.1,8.6Hz),3.06
(1H,dd,J=14.1,6.0Hz),4.17〜4.50(1H,m),4.62〜
4.97(2H,m),5.40(1H,d,J=4.2Hz),7.11〜7.45(5H,
m). (2R,3R)−体;δ1.16,1.22(6H,two d,J=each 6.0H
z),2.13(3H,s),2.97(2H,d,J=7.6Hz),4.17〜4.50
(1H,m),4.62〜4.97(2H,m),5.38(1H,d,J=4.1Hz),
7.11〜7.45(5H,m). MS(m/e):304(M+),245,206. 実施例2 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール30.0mg(0.13mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル26.8mg(0.11mmol)を塩化メチレン0.3mlに溶解し、
無水酢酸0.06ml(0.64mmol)、4−ジメチルアミノピリ
ジン0.17mg(0.0014mmol)、0.25Nシアン化ナトリウム
水溶液2.6ml(0.64mmol)を氷冷下順次加え、同温度で
3時間攪拌した。実施例1と同様に処理し、無色オイル
状の(2S,3R)−2−アセトキシ−3−イソプロポキシ
カルボニルアミノ−4−フェニルブチロニトリルとその
(2R,3R)−体との混合物5.7mg(19%:N−(イソプロポ
キシカルボニル)−(R)−フェニルアラニノールから
の通算収率)を得た。
Rf: 0.40 (hexane / ethyl acetate = 7/3) IR (neat): 1760,1700 cm -1 . NMR (CDCl 3 ): (2R, 3R) -form; δ1.16,1.22 (6H, two d, J = each 6.0H
z), 2.16 (3H, s), 2.89 (1H, dd, J = 14.1,8.6Hz), 3.06
(1H, dd, J = 14.1,6.0Hz), 4.17 ~ 4.50 (1H, m), 4.62 ~
4.97 (2H, m), 5.40 (1H, d, J = 4.2Hz), 7.11 ~ 7.45 (5H,
m). (2R, 3R) -body; δ1.16,1.22 (6H, two d, J = each 6.0H
z), 2.13 (3H, s), 2.97 (2H, d, J = 7.6Hz), 4.17 ~ 4.50
(1H, m), 4.62-4.97 (2H, m), 5.38 (1H, d, J = 4.1Hz),
7.11 to 7.45 (5H, m). MS (m / e): 304 (M + ), 245, 206. Example 2 26.8 mg (0.11 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 30.0 mg (0.13 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.3 ml of methylene chloride. Dissolves in
Acetic anhydride 0.06 ml (0.64 mmol), 4-dimethylaminopyridine 0.17 mg (0.0014 mmol), and 0.25 N sodium cyanide aqueous solution 2.6 ml (0.64 mmol) were sequentially added under ice cooling, and the mixture was stirred at the same temperature for 3 hours. Treated as in Example 1, colorless oily mixture of (2S, 3R) -2-acetoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form 5.7 mg. (19%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) was obtained.

(2S,3R)−体と(2R,3R)−体との生成比は実施例1と
同様にNMRスペクトル(400MHz)から10:1と決定した。
The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was determined to be 10: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例3 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール90.2mg(0.38mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル75.7mg(0.32mmol)を塩化メチレン0.9mlに溶解し、
無水酢酸0.18ml(1.9mmol)、4−ジメチルアミノピリ
ジン0.47mg(0.0038mmol)、塩化ベンジルトリブチルア
ンモニウム6.2mg(0.02mmol)、水0.52ml、5Nシアン化
ナトリウム水溶液0.38ml(1.9mmol)を氷冷下順次加
え、同温度で5時間攪拌した。実施例1と同様に処理し
て得た残渣を薄層クロマトグラフィー(シリカゲル、ヘ
キサン−酢酸エチル7:3)で精製し、無色オイル状の(2
S,3R)−2−アセトキシ−3−イソプロポキシカルボニ
ルアミノ−4−フェニルブチロニトリルとその(2R,3
R)−体との混合物54.2mg(47%:N−(イソプロポキシ
カルボニル)−(R)−フェニルアラニノールからの通
算収率)を得た。(2S,3R)−体と(2R,3R)−体との生
成比は実施例1と同様にNMRスペクトル(400MHz)から1
1:1と決定した。
Example 3 N- (isopropoxycarbonyl)-(R) -phenylalaninol 95.7 mg (0.32 mmol) obtained from 90.2 mg (0.38 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal was added to 0.9 ml of methylene chloride. Dissolves in
Acetic anhydride 0.18 ml (1.9 mmol), 4-dimethylaminopyridine 0.47 mg (0.0038 mmol), benzyltributylammonium chloride 6.2 mg (0.02 mmol), water 0.52 ml, 5N sodium cyanide aqueous solution 0.38 ml (1.9 mmol) were ice-cooled. The mixture was added in order downward and stirred at the same temperature for 5 hours. The residue obtained by the same treatment as in Example 1 was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 7: 3) to give a colorless oil (2
S, 3R) -2-acetoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R
This gave 54.2 mg (47%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) of a mixture with the R) -form. The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was 1 from the NMR spectrum (400 MHz) as in Example 1.
It was decided to be 1: 1.

実施例4 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール30.0mg(0.13mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル25.2mg(0.11mmol)を塩化メチレン0.3mlに溶解し、
無水酢酸0.06ml(0.64mmol)、ピリジン0.055ml(0.68m
mol)、塩化ベンジルトリブチルアンモニウム2.1mg(0.
007mmol)、0.25Nシアン化ナトリウム水溶液2.6ml(0.6
4mmol)を氷冷下順次加え、同温度で3時間攪拌した。
実施例1と同様に処理し、無色オイル状の(2S,3R)−
2−アセトキシ−3−イソプロポキシカルボニルアミノ
−4−フェニルブチロニトリルとその(2R,3R)−体と
の混合物11.1mg(37%:N−(イソプロポキシカルボニ
ル)−(R)−フェニルアラニノールからの通算収率)
を得た。
Example 4 25.2 mg (0.11 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 30.0 mg (0.13 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.3 ml of methylene chloride. Dissolves in
Acetic anhydride 0.06 ml (0.64 mmol), pyridine 0.055 ml (0.68 m
mol), benzyltributylammonium chloride 2.1 mg (0.
007mmol), 0.25N sodium cyanide aqueous solution 2.6ml (0.6
(4 mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 3 hours.
The same treatment as in Example 1 was carried out to give colorless oily (2S, 3R)-
A mixture of 2-acetoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form 11.1 mg (37%: N- (isopropoxycarbonyl)-(R) -phenylalaninol Total yield from)
I got

(2S,3R)−体と(2R,3R)−体との生成比は実施例1と
同様にNMRスペクトル(400MHz)から11:1と決定した。
The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was determined to be 11: 1 from the NMR spectrum (400 MHz) as in Example 1.

実施例5 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール30.0mg(0.13mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル25.6mg(0.11mmol)を塩化メチレン0.3mlに溶解し、
無水安息香酸0.12ml(0.64mmol)、4−ジメチルアミノ
ピリジン0.17mg(0.0014mmol)、塩化ベンジルトリブチ
ルアンモニウム2.1mg(0.007mmol)、0.25Nシアン化ナ
トリウム水溶液2.6ml(0.64mmol)を氷冷下順次加え、
同温度で3時間攪拌した。実施例1と同様に処理して得
た残渣を薄層クロマトグラフィー(シリカゲル、ヘキサ
ン−酢酸エチル7:3)で精製し、無色オイル状の(2S,3
R)−2−ベンゾキシ−3−イソプロポキシカルボニル
アミノ−4−フェニルブチロニトリルとその(2R,3R)
−体との混合物20.7mg(45%:N−(イソプロポキシカル
ボニル)−(R)−フェニルアラニノールからの通算収
率)を得た。(2S,3R)−体と(2R,3R)−体との生成比
は実施例1と同様にNMRスペクトル(400MHz)から9:1と
決定した。
Example 5 25.6 mg (0.11 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 30.0 mg (0.13 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.3 ml of methylene chloride. Dissolves in
Benzoic anhydride 0.12 ml (0.64 mmol), 4-dimethylaminopyridine 0.17 mg (0.0014 mmol), benzyltributylammonium chloride 2.1 mg (0.007 mmol), 0.25N aqueous sodium cyanide solution 2.6 ml (0.64 mmol) under ice cooling. In addition,
The mixture was stirred at the same temperature for 3 hours. The residue obtained by the same treatment as in Example 1 was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 7: 3) to give a colorless oily (2S, 3
R) -2-Benzoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R)
This gave 20.7 mg (45%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) of the mixture with the -form. The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was determined to be 9: 1 from the NMR spectrum (400 MHz) as in Example 1.

Rf:0.50(ヘキサン/酢酸エチル=7/3) IR(neat):1735,1725,1700cm-1. NMR(CDCl3): (2S,3R)−体;δ1.18,1.24(6H,two d,J=each 6.0H
z),2.90(1H,dd,J=14.1,8.6Hz),3.06(1H,dd,J=14.
1,6.1Hz),4.26〜5.00(3H,m),5.64(1H,d,J=4.6H
z),7.10〜7.75(8H,m),7.98〜8.18(2H,m). (2R,3R)−体;δ1.18,1.24(6H,two d,J=each 6.0H
z),2.98(2H,d,J=7.5Hz),4.26〜5.00(3H,m),5.63
(1H,d,J=4.4Hz),7.10〜7.75(8H,m),7.98〜8.18(2
H,m). MS(m/e):307,206. 実施例6 文献(Chem,Pharm.Bull.,30,1921(1982).参照)記
載の方法に従い、N−(ベンジルオキシカルボニル)−
(R)−フェニルアラニノール122mg(0.43mmol)より
得たN−(ベンジルオキシカルボニル)−(R)−フェ
ニルアラニナール98.6mg(0.35mmol)を塩化メチレン1.
8mlに溶解し、無水酢酸0.12ml(1.3mmol)、4−ジメチ
ルアミノピリジン0.54mg(0.0044mmol)、塩化ベンジル
トリブチルアンモニウム6.8mg(0.022mmol)、水1.55m
l、5Nシアン化ナトリウム水溶液0.26ml(1.3mmol)を氷
冷下順次加え、同温度で2時間攪拌した。実施例1と同
様に処理して得た残渣を薄層クロマトグラフィー(シリ
カゲル、ヘキサン−酢酸エチル7:3)で精製し、無色オ
イル状の(2S,3R)−2−アセトキシ−3−ベンジルオ
キシカルボニルアミノ−4−フェニルブチロニトリルと
その(2R,3R)−体との混合物84.4mg(56%:N−(ベン
ジルオキシカルボニル)−(R)−フェニルアラニノー
ルからの通算収率)を得た。(2S,3R)−体と(2R,3R)
−体との生成比は実施例1と同様にNMRスペクトル(400
MHz)から4:1と決定した。
Rf: 0.50 (hexane / ethyl acetate = 7/3) IR (neat): 1735, 1725, 1700 cm -1 . NMR (CDCl 3 ): (2S, 3R) -form; δ1.18,1.24 (6H, two d, J = each 6.0H
z), 2.90 (1H, dd, J = 14.1,8.6Hz), 3.06 (1H, dd, J = 14.
1,6.1Hz), 4.26 to 5.00 (3H, m), 5.64 (1H, d, J = 4.6H
z), 7.10 to 7.75 (8H, m), 7.98 to 8.18 (2H, m). (2R, 3R) -body; δ1.18,1.24 (6H, two d, J = each 6.0H
z), 2.98 (2H, d, J = 7.5Hz), 4.26 to 5.00 (3H, m), 5.63
(1H, d, J = 4.4Hz), 7.10 to 7.75 (8H, m), 7.98 to 8.18 (2
H, m). MS (m / e): 307,206. Example 6 According to the method described in the literature (see Chem, Pharm. Bull., 30 , 1921 (1982).), N- (benzyloxycarbonyl)-
98.6 mg (0.35 mmol) of N- (benzyloxycarbonyl)-(R) -phenylalaninal obtained from 122 mg (0.43 mmol) of (R) -phenylalaninol was added to methylene chloride 1.
Dissolve in 8 ml, acetic anhydride 0.12 ml (1.3 mmol), 4-dimethylaminopyridine 0.54 mg (0.0044 mmol), benzyltributylammonium chloride 6.8 mg (0.022 mmol), water 1.55 m
0.26 ml (1.3 mmol) of 5N sodium cyanide aqueous solution was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 2 hours. The residue obtained by the same treatment as in Example 1 was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 7: 3) to give (2S, 3R) -2-acetoxy-3-benzyloxy as a colorless oil. 84.4 mg (56%: total yield from N- (benzyloxycarbonyl)-(R) -phenylalaninol) of a mixture of carbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form was obtained. It was (2S, 3R) -body and (2R, 3R)
The production ratio with respect to the -form was the same as in Example 1 except that the NMR spectrum (400
Mhz) was determined to be 4: 1.

Rf:0.44(ヘキサン/酢酸エチル=7/3) IR(neat):1750,1710cm-1. NMR(CDCl3): (2S,3R)−体;δ2.13(3H,s),2.90(1H,dd,J=14.2,
8.7Hz),3.06(1H,dd,J=14.2,6.2Hz),4.34〜4.52(1
H,m),4.88〜5.03(1H,m),5.07(1H,d,J=12.1Hz),5.
08(1H,d.J=12.1Hz),5.40(1H,d,J=4.4Hz),7.10〜
7.44(10H,m). (2R,3R)−体;δ2.08(3H,s),2.98(2H,d,J=7.4H
z),4.34〜4.52(1H,m),4.88〜5.03(1H,m),5.07(1
H,d,J=12.1Hz),5.08(1H,d,J=12.1Hz),5.38(1H,d,
J=4.1Hz),7.10〜7.44(10H,m). MS(m/e):353(〔M+1〕+),261,207. 比較例1 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール50.0mg(0.21mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル42.3mg(0.18mmol)を塩化メチレン0.5mlに溶解し、
塩化ベンジルトリブチルアンモニウム3.4mg(0.011mmo
l)、水0.35ml、5Nシアン化ナトリウム水溶液0.21ml
(1.1mmol)を氷冷下順次加え、同温度で3.5時間攪拌し
た。実施例1と同様に処理し、粗製の(2S,3R)−2−
ヒドロキシ−3−イソプロポキシカルボニルアミノ−4
−フェニルブチロニトリルとその(2R,3R)−体との混
合物を得た。この混合物に無水酢酸0.25ml、ピリジン0.
5ml、触媒量の4−ジメチルアミノピリジンを加え、室
温で1.5時間攪拌した。反応液に1M塩酸を加え、エーテ
ルで抽出し、抽出液を飽和食塩水、飽和硫酸銅水溶液、
飽和食塩水、1M水酸化ナトリウム水溶液、および飽和食
塩水で順次洗浄した。無水硫酸ナトリウム上で乾燥後、
減圧下に濃縮し、残渣を薄層クロマトグラフィー(シリ
カゲル、ヘキサン−酢酸エチル7:3)で精製し、無色オ
イル状の(2S,3R)−2−アセトキシ−3−イソプロポ
キシカルボニルアミノ−4−フェニルブチロニトリルと
その(2R,3R)−体との混合物38.9mg(61%:N−(イソ
プロポキシカルボニル)−(R)−フェニルアラニノー
ルからの通算収率)を得た。(2S,3R)−体と(2R,3R)
−体との生成比は実施例1と同様にNMRスペクトル(400
MHz)から1:1と決定した。
Rf: 0.44 (hexane / ethyl acetate = 7/3) IR (neat): 1750,1710 cm -1 . NMR (CDCl 3 ): (2S, 3R) -form; δ2.13 (3H, s), 2.90 (1H, dd, J = 14.2,
8.7Hz), 3.06 (1H, dd, J = 14.2,6.2Hz), 4.34 to 4.52 (1
H, m), 4.88 to 5.03 (1H, m), 5.07 (1H, d, J = 12.1Hz), 5.
08 (1H, dJ = 12.1Hz), 5.40 (1H, d, J = 4.4Hz), 7.10 ~
7.44 (10H, m). (2R, 3R) -body; δ2.08 (3H, s), 2.98 (2H, d, J = 7.4H
z), 4.34 to 4.52 (1H, m), 4.88 to 5.03 (1H, m), 5.07 (1
H, d, J = 12.1Hz), 5.08 (1H, d, J = 12.1Hz), 5.38 (1H, d,
J = 4.1Hz), 7.10 to 7.44 (10H, m). MS (m / e): 353 ([M + 1] + ), 261,207. Comparative Example 1 42.3 mg (0.18 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 50.0 mg (0.21 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.5 ml of methylene chloride. Dissolves in
Benzyltributylammonium chloride 3.4 mg (0.011 mmo
l), water 0.35 ml, 5N sodium cyanide aqueous solution 0.21 ml
(1.1 mmol) was sequentially added under ice cooling, and the mixture was stirred at the same temperature for 3.5 hours. Treated as in Example 1 to give crude (2S, 3R) -2-
Hydroxy-3-isopropoxycarbonylamino-4
A mixture of -phenylbutyronitrile and its (2R, 3R) -form was obtained. To this mixture 0.25 ml acetic anhydride, pyridine 0.
5 ml and a catalytic amount of 4-dimethylaminopyridine were added, and the mixture was stirred at room temperature for 1.5 hours. 1M hydrochloric acid was added to the reaction solution, which was extracted with ether, and the extract solution was saturated saline solution, saturated copper sulfate aqueous solution,
The extract was washed successively with saturated saline, 1M aqueous sodium hydroxide solution, and saturated saline. After drying over anhydrous sodium sulfate,
After concentration under reduced pressure, the residue was purified by thin layer chromatography (silica gel, hexane-ethyl acetate 7: 3), and colorless oily (2S, 3R) -2-acetoxy-3-isopropoxycarbonylamino-4- 38.9 mg (61%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) of a mixture of phenylbutyronitrile and its (2R, 3R) -form was obtained. (2S, 3R) -body and (2R, 3R)
The production ratio with respect to the -form was the same as in Example 1 except that the NMR spectrum (400
MHz) was determined to be 1: 1.

比較例2 N−(イソプロポキシカルボニル)−(R)−フェニ
ルアラニノール30.0mg(0.13mmol)より得たN−(イソ
プロポキシカルボニル)−(R)−フェニルアラニナー
ル25.0mg(0.11mmol)を塩化メチレン0.3mlに溶解し、
氷冷下0.25Nシアン化ナトリウム水溶液2.6ml(0.64mmo
l)を加え、同温度で3時間攪拌した。実施例1と同様
に処理し、粗製の(2S,3R)−2−ヒドロキシ−3−イ
ソプロポキシカルボニルアミノ−4−フェニルブチロニ
トリルとその(2R,3R)−体との混合物を得た。この混
合物に無水酢酸0.15ml、ピリジン0.3ml、触媒量の4−
ジメチルアミノピリジンを加え、室温で2時間攪拌し
た。比較例1と同様に処理し、無色オイル状の(2S,3
R)−2−アセトキシ−3−イソプロポキシカルボニル
アミノ−4−フェニルブチロニトリルとその(2R,3R)
−体との混合物17.9mg(60%:N−(イソプロポキシカル
ボニル)−(R)−フェニルアラニノールからの通算収
率)を得た。(2S,3R)−体と(2R,3R)−体との生成比
は実施例1と同様にNMRスペクトル(400MHz)から1:1と
決定した。
Comparative Example 2 25.0 mg (0.11 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninal obtained from 30.0 mg (0.13 mmol) of N- (isopropoxycarbonyl)-(R) -phenylalaninol was added to 0.3 ml of methylene chloride. Dissolves in
2.6 ml of 0.25N sodium cyanide aqueous solution under ice cooling (0.64 mmo
l) was added, and the mixture was stirred at the same temperature for 3 hours. The mixture was treated in the same manner as in Example 1 to obtain a crude mixture of (2S, 3R) -2-hydroxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form. To this mixture 0.15 ml acetic anhydride, 0.3 ml pyridine, catalytic amount of 4-
Dimethylaminopyridine was added, and the mixture was stirred at room temperature for 2 hours. The same treatment as in Comparative Example 1 was conducted to obtain colorless oily (2S, 3
R) -2-acetoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R)
17.9 mg (60%: total yield from N- (isopropoxycarbonyl)-(R) -phenylalaninol) of a mixture with the -form was obtained. The production ratio of the (2S, 3R) -form and the (2R, 3R) -form was determined to be 1: 1 from the NMR spectrum (400 MHz) as in Example 1.

参考例4 (2S,3R)−2−アセトキシ−3−イソプロポキシカ
ルボニルアミノ−4−フェニルブチルニトリルとその
(2R,3R)−体との11:1混合物54.2mg(0.18mmol)を酢
酸エチル3mlに溶解し、水3ml、濃塩酸3mlを加え、反応
液を100℃に加熱して酢酸エチルを留去した。さらに濃
塩酸1.5mlを加え80℃で10.5時間加熱攪拌した。反応液
を減圧下濃縮乾固し、(2S,3R)−3−アミノ−2−ヒ
ドロキシ−4−フェニル酪酸塩酸塩とその(2R,3R)−
体との11:1混合物51.6mgを定量的に得た。
Reference example 4 54.2 mg (0.18 mmol) of an 11: 1 mixture of (2S, 3R) -2-acetoxy-3-isopropoxycarbonylamino-4-phenylbutylnitrile and its (2R, 3R) -form was dissolved in 3 ml of ethyl acetate. , 3 ml of water and 3 ml of concentrated hydrochloric acid were added and the reaction solution was heated to 100 ° C. to distill off ethyl acetate. Further, 1.5 ml of concentrated hydrochloric acid was added, and the mixture was heated with stirring at 80 ° C for 10.5 hours. The reaction solution was concentrated to dryness under reduced pressure, and (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid hydrochloride and its (2R, 3R)-
51.6 mg of an 11: 1 mixture with the body was obtained quantitatively.

NMR(D2O): (2S,3R)−体;δ3.01(1H,dd,J=14.1,8.1Hz),3.16
(1H,dd,J=14.1,7.3Hz),3.94(1H,dt,J=7.7,3.3H
z),4.32(1H,d,J=3.3Hz),7.33〜7.47(5H,m). (2R,3R)−体;δ2.95(1H,dd,J=14.3,9.2Hz),3.03
(1H,dd,J=14.1,5.9Hz),4.05〜4.75(1H,m),4.60(1
H,d,J=3.0Hz),7.33〜7.47(5H,m). 参考例5 (2S,3R)−2−ベンゾキシ−3−イソプロポキシカ
ルボニルアミノ−4−フェニルブチロニトリルとその
(2R,3R)−体との9:1混合物20.7mg(0.056mmol)を酢
酸エチル1.5mlに溶解し、水1.5ml、濃塩酸1.5mlを加
え、反応液を100℃に加熱して酢酸エチルを留去した。
さらに濃塩酸0.75mlを加え80℃で10.5時間加熱攪拌し
た。反応液を減圧下濃縮乾固し、(2S,3R)−3−アミ
ノ−2−ヒドロキシ−4−フェニル酪酸塩酸塩とその
(2R,3R)−体との9:1混合物15.5mgを定量的に得た。
NMR (D 2 O): (2S, 3R) -form; δ3.01 (1H, dd, J = 14.1,8.1Hz), 3.16
(1H, dd, J = 14.1,7.3Hz), 3.94 (1H, dt, J = 7.7,3.3H
z), 4.32 (1H, d, J = 3.3Hz), 7.33 to 7.47 (5H, m). (2R, 3R) -body; δ2.95 (1H, dd, J = 14.3,9.2Hz), 3.03
(1H, dd, J = 14.1,5.9Hz), 4.05 to 4.75 (1H, m), 4.60 (1
H, d, J = 3.0Hz), 7.33 to 7.47 (5H, m). Reference example 5 20.7 mg (0.056 mmol) of a 9: 1 mixture of (2S, 3R) -2-benzoxy-3-isopropoxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form was added to 1.5 ml of ethyl acetate. After dissolution, 1.5 ml of water and 1.5 ml of concentrated hydrochloric acid were added and the reaction solution was heated to 100 ° C. to distill off ethyl acetate.
Furthermore, 0.75 ml of concentrated hydrochloric acid was added, and the mixture was heated with stirring at 80 ° C. for 10.5 hours. The reaction mixture was concentrated to dryness under reduced pressure, and 15.5 mg of a 9: 1 mixture of (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid hydrochloride and its (2R, 3R) -form was quantitatively determined. Got to.

参考例6 (2S,3R)−2−アセトキシ−3−ベンジルオキシカ
ルボニルアミノ−4−フェニルブチロニトリルとその
(2R,3R)−体との4:1混合物74.5mg(0.21mmol)を酢酸
エチル4.5mlに溶解し、水2.0ml、濃塩酸2.9mlを加え、
反応液を100℃に加熱して酢酸エチルを留去した。さら
に濃塩酸1.2mlを加え80℃で11時間加熱攪拌した。反応
液を減圧下濃縮乾固し、(2S,3R)−3−アミノ−2−
ヒドロキシ−4−フェニル酪酸塩酸塩とその(2R,3R)
−体との4:1混合物59.0mgを定量的に得た。
Reference example 6 74.5 mg (0.21 mmol) of a 4: 1 mixture of (2S, 3R) -2-acetoxy-3-benzyloxycarbonylamino-4-phenylbutyronitrile and its (2R, 3R) -form was added to 4.5 ml of ethyl acetate. Dissolve, add 2.0 ml of water, 2.9 ml of concentrated hydrochloric acid,
The reaction solution was heated to 100 ° C. and ethyl acetate was distilled off. Further, 1.2 ml of concentrated hydrochloric acid was added, and the mixture was heated with stirring at 80 ° C. for 11 hours. The reaction solution was concentrated to dryness under reduced pressure, and (2S, 3R) -3-amino-2-
Hydroxy-4-phenylbutyric acid hydrochloride and its (2R, 3R)
-Quantitatively 59.0 mg of a 4: 1 mixture with the body was obtained.

参考例7 (2S,3R)−3−アミノ−2−ヒドロキシ−4−フェ
ニル酪酸塩酸塩とその(2R,3R)−体との4:1混合物170m
g(0.73mmol)をメタノール10mlに溶解し、氷冷下塩化
チオニル0.31ml(4.3mmol)を滴下した。同温度で1時
間攪拌した後徐々に昇温し、2時間加熱還流を行なっ
た。反応液を減圧下に濃縮し、(2S,3R)−3−アミノ
−2−ヒドロキシ−4−フェニル酪酸メチル塩酸塩とそ
の(2R,3R)−体との混合物を得た。
Reference example 7 170m 4: 1 mixture of (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid hydrochloride and its (2R, 3R) -form
g (0.73 mmol) was dissolved in 10 ml of methanol, and 0.31 ml (4.3 mmol) of thionyl chloride was added dropwise under ice cooling. After stirring at the same temperature for 1 hour, the temperature was gradually raised and the mixture was heated under reflux for 2 hours. The reaction solution was concentrated under reduced pressure to obtain a mixture of (2S, 3R) -3-amino-2-hydroxy-4-phenylbutyric acid methyl hydrochloride and its (2R, 3R) -form.

(2S,3R)−体と(2R,3R)−体との混合物であるメチ
ルエステル塩酸塩にピリジン3.0ml、無水酢酸1.5ml、触
媒量の4−ジメチルアミノピリジンを加えて室温で16.5
時間攪拌した。反応液に1M塩酸を加え、エーテルで抽出
し、抽出液を飽和食塩水、飽和硫酸銅水溶液、飽和食塩
水、1M水酸化ナトリウム水溶液、および飽和食塩水で順
次洗浄した。無水硫酸ナトリウム上で乾燥後、減圧下に
濃縮し、(2S,3R)−2−アセトキシ−3−アセチルア
ミノ−4−フェニル酪酸メチルとその(2R,3R)−体と
の混合物を得た。この混合物を薄層クロマトグラフィー
(シリカゲル、酢酸エチル)で分離精製し、(2S,3R)
−体67.9mg(32%)および(2R,3R)−体16.7mg(8
%)を各々無色オイル状として得た。
To the methyl ester hydrochloride, which is a mixture of the (2S, 3R) -form and the (2R, 3R) -form, 3.0 ml of pyridine, 1.5 ml of acetic anhydride and a catalytic amount of 4-dimethylaminopyridine were added, and the mixture was mixed at 16.5 at room temperature.
Stir for hours. 1M Hydrochloric acid was added to the reaction solution, which was extracted with ether. The extract was washed with saturated saline, saturated copper sulfate aqueous solution, saturated saline, 1M sodium hydroxide aqueous solution, and saturated saline in this order. After drying over anhydrous sodium sulfate, the mixture was concentrated under reduced pressure to obtain a mixture of methyl (2S, 3R) -2-acetoxy-3-acetylamino-4-phenylbutyrate and its (2R, 3R) -form. This mixture was separated and purified by thin layer chromatography (silica gel, ethyl acetate), (2S, 3R).
-Body 67.9 mg (32%) and (2R, 3R) -body 16.7 mg (8
%) As a colorless oil.

(2S,3R)−2−アセトキシ−3−アセチルアミノ−
4−フェニル酪酸メチル; Rf:0.44(酢酸エチル). ▲〔α〕20 D▼+55.2°(c=0.145,クロロホルム). IR(neat):1745,1660,1550cm-1. NMR(CDCl3):δ1.96(3H,s),2.23(3H,s),2.79(1
H,dd,J=13.6,9.0Hz),2.94(1H,dd,J=13.6,6.6Hz),
3.69(3H,s),4.79(1H,ddt,J=9.0,6.6,2.2Hz),4.90
(1H,d,J=2.2Hz),5.73(1H,brd,J=9.0Hz),7.14〜7.
34(5H,m). MS(m/e):294(〔M+1〕+),293(M+),234,202,19
2. (2S,3R)−2−アセトキシ−3−アセチルアミノ−4
−フェニル酪酸メチル; Rf:0.56(酢酸エチル). ▲〔α〕20 D▼+0.00°(c=0.123,クロロホルム). IR(neat):1750,1645,1550cm-1. NMR(CDCl3):δ1.91(3H,s),2.18(3H,s),2.87(2
H,d,J=7.2Hz),3.70(3H,s),4.79(1H,ddt,J=8.8,7.
2,4.3Hz),5.11(1H,d,J=4.3Hz),5.56(1H,brd,J=8.
8Hz),7.17〜7.34(5H,m). MS(m/e):294(〔M+1〕+),293(M+),234,202,19
2. (2S,3R)−2−アセトキシ−3−アセチルアミノ−4
−フェニル酪酸メチル82.9mg(0.28mmol)を酢酸エチル
2mlに溶解し、水2ml、濃塩酸2mlを加え反応液を100℃に
加熱して酢酸エチルを留去した。さらに80℃で10時間加
熱攪拌した後、反応液を減圧下約0.5mlまで濃縮し、一
晩放置後、析出結晶を濾取した。トルエンで洗浄後、減
圧下に乾燥し、白色結晶の(2S,3R)−3−アミノ−2
−ヒドロキシ−4−フェニル酪酸塩酸塩28.8mg(44%)
を得た。
(2S, 3R) -2-acetoxy-3-acetylamino-
Methyl 4-phenylbutyrate; Rf: 0.44 (ethyl acetate). ▲ [α] 20 D ▼ + 55.2 ° (c = 0.145, chloroform). IR (neat): 1745,1660,1550cm -1 . NMR (CDCl 3 ): δ1.96 (3H, s), 2.23 (3H, s), 2.79 (1
H, dd, J = 13.6,9.0Hz), 2.94 (1H, dd, J = 13.6,6.6Hz),
3.69 (3H, s), 4.79 (1H, ddt, J = 9.0,6.6,2.2Hz), 4.90
(1H, d, J = 2.2Hz), 5.73 (1H, brd, J = 9.0Hz), 7.14 to 7.
34 (5H, m). MS (m / e): 294 ([M + 1] + ), 293 (M + ), 234,202,19
2. (2S, 3R) -2-acetoxy-3-acetylamino-4
-Methyl phenylbutyrate; Rf: 0.56 (ethyl acetate). ▲ [α] 20 D ▼ + 0.00 ° (c = 0.123, chloroform). IR (neat): 1750,1645,1550cm -1 . NMR (CDCl 3 ): δ1.91 (3H, s), 2.18 (3H, s), 2.87 (2
H, d, J = 7.2Hz), 3.70 (3H, s), 4.79 (1H, ddt, J = 8.8,7.
2,4.3Hz), 5.11 (1H, d, J = 4.3Hz), 5.56 (1H, brd, J = 8.
8Hz), 7.17 to 7.34 (5H, m). MS (m / e): 294 ([M + 1] + ), 293 (M + ), 234,202,19
2. (2S, 3R) -2-acetoxy-3-acetylamino-4
-Methyl phenylbutyrate 82.9 mg (0.28 mmol) in ethyl acetate
It was dissolved in 2 ml, water (2 ml) and concentrated hydrochloric acid (2 ml) were added, and the reaction mixture was heated to 100 ° C. to distill off ethyl acetate. After further heating and stirring at 80 ° C. for 10 hours, the reaction solution was concentrated under reduced pressure to about 0.5 ml and left overnight, and then the precipitated crystals were collected by filtration. After washing with toluene, it was dried under reduced pressure to obtain white crystals of (2S, 3R) -3-amino-2.
-Hydroxy-4-phenylbutyric acid hydrochloride 28.8 mg (44%)
I got

▲〔α〕22 D▼+25.7°(c=0.700,1NHCl). 〔文献値:J.Antibiot.,29,100(1976);▲〔α〕22 D
+27.9°(c=0.717,1NHCl)〕. IR(KBr):1740cm-1. NMR(D2O):δ3.01(1H,dd,J=14.1,8.1Hz),3.16(1
H,dd,J=14.1,7.3Hz),3.94(1H,dt,J=7.7,3.3Hz),4.
32(1H,d,J=3.3Hz),7.33〜7.47(5H,m). このNMRスペクトルは文献(J.Antibiot.,29,100(197
6).)記載のものに一致した。
▲ [α] 22 D ▼ + 25.7 ° (c = 0.700,1N HCl). [Reference value: J. Antibiot., 29 , 100 (1976); ▲ [α] 22 D
+ 27.9 ° (c = 0.717, 1N HCl)]. IR (KBr): 1740 cm -1 . NMR (D 2 O): δ3.01 (1H, dd, J = 14.1,8.1Hz), 3.16 (1
H, dd, J = 14.1,7.3Hz), 3.94 (1H, dt, J = 7.7,3.3Hz), 4.
32 (1H, d, J = 3.3Hz), 7.33 to 7.47 (5H, m). This NMR spectrum can be found in the literature (J. Antibiot., 29 , 100 (197
6). ) Matched with the one described.

MS(m/e):196(〔MH-HCl〕+),150,120,104.MS (m / e): 196 ((MH-HCl) + ), 150,120,104.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 常本 大英 神奈川県座間市緑ケ丘2―24―5 審査官 今村 玲英子 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Daiei Tsunemoto 2-24-5 Midorigaoka, Zama City, Kanagawa Examiner Reiko Imamura

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中、R1は炭素数1〜4の直鎖もしくは分枝アルカノ
イル基、塩素原子もしくはメトキシ基で置換されていて
もよいアロイル基、炭素数1〜5の直鎖もしくは分枝ア
ルコキシカルボニル基、または塩素原子もしくはメトキ
シ基で置換されていてもよいアラルコキシカルボニル基
を表し、R2は水素原子、炭素数1〜4の直鎖もしくは分
枝アルキル基、または塩素原子もしくはメトキシ基で置
換されていてもよいアリール基を表す。)で表される
(2S,3R)−3−アミノ−2−アシルオキシ−4−フェ
ニルブチロニトリル誘導体。
1. A general formula (In the formula, R 1 is a linear or branched alkanoyl group having 1 to 4 carbon atoms, an aroyl group optionally substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms. Or a aralkoxycarbonyl group which may be substituted with a chlorine atom or a methoxy group, and R 2 is substituted with a hydrogen atom, a linear or branched alkyl group having 1 to 4 carbon atoms, or a chlorine atom or a methoxy group. (2S, 3R) -3-amino-2-acyloxy-4-phenylbutyronitrile derivative represented by (representing an optionally substituted aryl group).
【請求項2】一般式 (式中、R1は炭素数1〜4の直鎖もしくは分枝アルカノ
イル基、塩素原子もしくはメトキシ基で置換されていて
もよいアロイル基、炭素数1〜5の直鎖もしくは分枝ア
ルコキシカルボニル基、または塩素原子もしくはメトキ
シ基で置換されていてもよいアラルコキシカルボニル基
を表す。)で表される(R)−2−アミノ−3−フェニ
ルプロパナール誘導体と一般式 R2COOCOR3 (式中、R2、R3は各々独立に、水素原子、炭素数1〜4
の直鎖もしくは分枝アルキル基、または塩素原子もしく
はメトキシ基で置換されていてもよいアリール基を表
す。)で表されるカルボン酸無水物および青酸塩と第4
級アンモニウム塩および/または第3級アミンの存在下
反応させることを特徴とする、 一般式 (式中、R1およびR2は前記と同じ意味を表す。)で表さ
れる(2S,3R)−3−アミノ−2−アシルオキシ−4−
フェニルブチロニトリル誘導体の製造方法。
2. General formula (In the formula, R 1 is a linear or branched alkanoyl group having 1 to 4 carbon atoms, an aroyl group optionally substituted with a chlorine atom or a methoxy group, a linear or branched alkoxycarbonyl group having 1 to 5 carbon atoms. , Or an aralkoxycarbonyl group which may be substituted with a chlorine atom or a methoxy group.) And an (R) -2-amino-3-phenylpropanal derivative represented by the general formula R 2 COOCOR 3 (formula In the formula, R 2 and R 3 are each independently a hydrogen atom or a carbon number of 1 to 4.
Represents a linear or branched alkyl group, or an aryl group which may be substituted with a chlorine atom or a methoxy group. ) And carboxylic anhydrides and cyanates represented by
General formula characterized by reacting in the presence of a primary ammonium salt and / or a tertiary amine (In the formula, R 1 and R 2 have the same meanings as described above.) (2S, 3R) -3-amino-2-acyloxy-4-
Method for producing phenylbutyronitrile derivative.
JP63165910A 1988-07-05 1988-07-05 (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same Expired - Lifetime JPH0819072B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63165910A JPH0819072B2 (en) 1988-07-05 1988-07-05 (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63165910A JPH0819072B2 (en) 1988-07-05 1988-07-05 (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same

Publications (2)

Publication Number Publication Date
JPH0217165A JPH0217165A (en) 1990-01-22
JPH0819072B2 true JPH0819072B2 (en) 1996-02-28

Family

ID=15821332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63165910A Expired - Lifetime JPH0819072B2 (en) 1988-07-05 1988-07-05 (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same

Country Status (1)

Country Link
JP (1) JPH0819072B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36718E (en) * 1993-06-29 2000-05-30 Kaneka Corporation Optically active aminoalcohol derivatives and method of producing same
WO1997029082A1 (en) * 1996-02-08 1997-08-14 Nippon Kayaku Kabushiki Kaisha Process for producing optically active cyanohydrins
JPH10231280A (en) * 1996-12-20 1998-09-02 Sagami Chem Res Center Method for producing 3-amino-2-hydroxy-4-phenylbutyronitrile derivative

Also Published As

Publication number Publication date
JPH0217165A (en) 1990-01-22

Similar Documents

Publication Publication Date Title
JP2711244B2 (en) Novel acetoacetic ester and method for producing the same
JPH05239021A (en) Novel actinonine derivative
WO1992022560A1 (en) Optically active intermediate and production thereof
JP2691442B2 (en) Novel proline derivative
JPH0819072B2 (en) (2S, 3R) -3-Amino-2-acyloxy-4-phenylbutyronitrile derivative and method for producing the same
EP1063232B1 (en) Process for producing erythro-3-amino-2-hydroxybutyric acid derivatives
JP2006525294A (en) Process for producing 4-hydroxyisoleucine and its derivatives
KR100491748B1 (en) Optically active erythro-3-amino-2-hydroxybutyric esters and process for preparing said esters
JP2860559B2 (en) Preparation of stereospecific intermediates useful for peptide derivative synthesis
JP3207017B2 (en) Method for producing benzylsuccinic acid derivative and intermediate for producing the same
JPH0819071B2 (en) 3-Amino-2-acyloxy-butyronitrile derivative and method for producing the same
Fernández-Suárez et al. Asymmetric synthesis of the β-amino acid methyl ester derivative of onchidin:(2S, 3S)-methyl-3-amino-2-methyl-7-octynoate and its enantiomer
KR0163770B1 (en) Method for preparing 3,4-epoxybutyrate and intermediates therefor
JPS6053039B2 (en) N-Acetyl/Iramic acid derivative and method for producing the same
US20040049074A1 (en) Process for producing 3-amino-2-hydroxypropionic acid derivatives
JP3997141B2 (en) Tyropeptin A analog
JPH0780839B2 (en) Method for producing azetidinones
JPH0830049B2 (en) Process for producing 4-amino-3-hydroxypentanoic acid derivative
JP3740783B2 (en) Process for producing 4- (2-alkenyl) -2,5-oxazolidinediones
JPH0259545A (en) 3-amino-2-hydroxy-1-nitrobutane derivative and production of alpha-hydroxy-beta-amino acid
JPH083132A (en) Prolylproline derivative and its new production
JP2005263748A (en) Homophenylalanine derivatives having reactive diazirine groups
JP3864672B2 (en) Method for producing erythro-3-amino-2-hydroxybutyric acid derivative
JP2005298337A (en) Process for producing β-hydroxyamino acid derivative and its intermediate
JPS6254310B2 (en)